G.S. Murkitt

Liquid—solid sample preparation in drug analysis

R.D. McDowall, J.C. Pearce, G.S. Murkitt · Journal of Pharmaceutical and Biomedical Analysis · 1986 · 91 citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +12

The Cyclooxygenase-2 Inhibitor GW406381X [2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] Is Effective in Animal Models of Neuropathic Pain and Central Sensitization

Sharon Bingham, Paul Beswick, C. Bountra et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 63 citations

Medicine, Pharmacology, Pharmacotherapy +17

New quinoline NK3 receptor antagonists with CNS activity

Paul W. Smith, Paul Wyman, Peter J. Lovell et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 58 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

The discovery of a potent, intracellular, orally bioavailable, long duration inhibitor of human neutrophil elastase—GW311616A a development candidate

Simon J. F. Macdonald, Michael D. Dowle, Lee A. Harrison et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 46 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

In Vitro and In Vivo Characterization of the Non-peptide NK3 Receptor Antagonist SB-223412 (Talnetant): Potential Therapeutic Utility in the Treatment of Schizophrenia

Lee A. Dawson, Katherine J Cato, Claire M. Scott et al. · Neuropsychopharmacology · 2007 · 44 citations

Medicine, Pharmacology, Psychiatry +13